Hematologic malignancies of the liver: spectrum of disease

A Tomasian, K Sandrasegaran, KM Elsayes… - Radiographics, 2015 - pubs.rsna.org
The incidence of hematologic malignancies and their extranodal manifestations is
continuously increasing. Previously unsuspected hepatic involvement in hematologic …

Utility of FDG PET/CT in the assessment of myeloid sarcoma

EYP Lee, MP Anthony, AYH Leung… - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. Myeloid sarcoma (MS) is a rare extramedullary manifestation of acute myeloid
leukemia that often presents during remission or disease relapse. With awareness of this …

[HTML][HTML] 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia

F Stölzel, C Röllig, J Radke, B Mohr, U Platzbecker… - …, 2011 - ncbi.nlm.nih.gov
Myeloid sarcoma in acute myeloid leukemia has been clearly defined by the World Health
Organization but studies regarding the prevalence and the prognostic impact of …

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial

F Stölzel, T Lüer, S Löck, S Parmentier… - …, 2019 - pmc.ncbi.nlm.nih.gov
Extramedullary (EM) disease in patients with acute myeloid leukemia (AML) is a known
phenomenon. Since the prevalence of EM AML has so far only been clinically determined …

18FDG‐PET/CT: 21st century approach to leukemic tumors in 124 cases

I Cunningham, B Kohno - American journal of hematology, 2016 - Wiley Online Library
Extramedullary tumors remain an obstacle to curing more acute leukemia patients. Their
incidence is unknown because the presence of occult tumors that contribute to relapse is not …

[HTML][HTML] Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of …

S Yoshihara, T Ando, H Ogawa - Biology of Blood and Marrow …, 2012 - Elsevier
Acute myeloid leukemia may manifest as myeloid sarcoma in a variety of extramedullary
(EM) tissues at diagnosis or at relapse. Although EM relapse after allogeneic hematopoietic …

Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma

P Aschoff, M Häntschel, M Öksüz… - Nuklearmedizin …, 2009 - thieme-connect.com
Aim: Granulocytic sarcomas (GS) are rare extramedullary manifestations of myeloid or
lymphoblastic leukaemia. Laboratory examinations are of limited use for diagnosis of …

FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy

K Ueda, M Ichikawa, M Takahashi, T Momose… - Leukemia research, 2010 - Elsevier
Granulocytic sarcomas (GSs) are extramedullary tumors that consist of myeloid cells in
patients with myeloid malignancies. The role for 18F-fluorodeoxyglucose-positron-emission …

Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome

S Yoshihara, K Ikegame, K Kaida, K Taniguchi… - Bone marrow …, 2012 - nature.com
Extramedullary (EM) relapse of leukemia after allo-SCT in patients with
AML/myelodysplastic syndrome has been increasingly reported. The reduced effectiveness …

Isolated pancreatic myeloid sarcoma associated with t (8; 21)/RUNX1-RUNX1T1 rearrangement

K Tokunaga, A Yamamura, S Ueno, Y Kikukawa… - Internal …, 2018 - jstage.jst.go.jp
No valid treatment for isolated myeloid sarcoma (IMS) has yet been established, and no
thorough genetic examinations have been performed because of its low incidence and …